Cuu Long Pharmaceutical JSC (HOSE:DCL)
Vietnam · Delayed Price · Currency is VND 39,000
+300 (0.78%)
At close: May 22, 2026
HOSE:DCL Cash Flow Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -7,322 | 19,516 | 53,571 | 61,717 | 111,641 | 85,961 |
Depreciation & Amortization | 54,728 | 53,005 | 38,258 | 38,278 | 38,135 | 34,273 |
Other Amortization | 520.61 | 410.94 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | - | - | -8,884 | -25,617 | -43,737 |
Other Operating Activities | 16,993 | 3,796 | -5,065 | 5,872 | 7,005 | -4,989 |
Change in Accounts Receivable | 154,785 | 36,341 | 8,662 | -14,709 | -384,124 | -105,671 |
Change in Inventory | -13,695 | -21,294 | 16,311 | -55,033 | -9,758 | -83,805 |
Change in Accounts Payable | -55,594 | -37,388 | -27,074 | -1,479 | -161,826 | 214,295 |
Change in Other Net Operating Assets | -1,131 | -6,596 | -4,850 | -3,233 | -1,001 | 3,380 |
Operating Cash Flow | 139,387 | 47,791 | 69,813 | 22,530 | -450,071 | 29,437 |
Operating Cash Flow Growth | 260.57% | -31.55% | 209.86% | - | - | -68.47% |
Capital Expenditures | -117,003 | -88,040 | -172,850 | -222,874 | -233,028 | -152,612 |
Sale of Property, Plant & Equipment | - | - | - | 370.64 | 250.12 | - |
Investment in Securities | -1,000 | - | - | 44,346 | 292,923 | - |
Other Investing Activities | -12,473 | -12,974 | 6,467 | 9,151 | 33,032 | 56,947 |
Investing Cash Flow | -130,476 | -101,013 | -166,382 | -169,006 | 93,177 | 224,393 |
Long-Term Debt Issued | - | 1,204,636 | 1,199,477 | 973,672 | 1,218,898 | 2,427,584 |
Long-Term Debt Repaid | - | -1,181,044 | -1,075,364 | -856,533 | -1,205,603 | -2,702,031 |
Net Debt Issued (Repaid) | -17,153 | 23,592 | 124,113 | 117,138 | 13,295 | -274,447 |
Issuance of Common Stock | - | - | - | - | 355,205 | 20,000 |
Financing Cash Flow | -17,153 | 23,592 | 124,113 | 117,138 | 368,500 | -254,447 |
Foreign Exchange Rate Adjustments | 1.64 | -0.05 | 8.1 | 2.59 | -8.99 | -5.76 |
Net Cash Flow | -8,241 | -29,631 | 27,552 | -29,335 | 11,596 | -622.67 |
Free Cash Flow | 22,384 | -40,249 | -103,037 | -200,343 | -683,099 | -123,174 |
Free Cash Flow Margin | 1.71% | -3.05% | -7.89% | -17.51% | -67.25% | -17.51% |
Free Cash Flow Per Share | 306.46 | -551.05 | -1410.67 | -2742.89 | -9736.25 | -2142.18 |
Cash Interest Paid | 49,518 | 49,064 | 25,437 | 29,199 | 35,991 | 33,237 |
Cash Income Tax Paid | 2,135 | 13,120 | 14,964 | 12,576 | 25,261 | 33,440 |
Levered Free Cash Flow | -158,007 | -37,183 | -134,124 | -187,565 | -814,492 | -31,418 |
Unlevered Free Cash Flow | -125,484 | -6,477 | -118,190 | -168,484 | -789,725 | -8,753 |
Change in Working Capital | 74,467 | -28,938 | -16,951 | -74,453 | -581,234 | -42,071 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.